Results 141 to 150 of about 46,891 (297)
Basic and Clinical Neuroscience, 2017 Introduction: Recent studies demonstrated that cannabidiol had neuroprotective property. Thereis some evidence about effective role of cannabidiol in reducing ischemic damages. It has been reported that infarct size is influenced by various factors after
Sepideh Khaksar, Mohammad Reza Bigdeli
doaj
PharmaceuticalsRefractoriness to antiseizure medications is still a major concern in the pharmacotherapy of epilepsy. For this reason, we decided to evaluate the combination of levetiracetam and cannabidiol, administered at a subthreshold dose, to limit the possible ...
Chiara Lucchi +5 more
doaj +1 more source
Stable dose cannabinoid medicine (Sativex®, THC+CBD) can provide sustained efficacy in the treatment of refractory painful diabetic neuropathy or other peripheral neuropathic pain associated with allodynia [poster] [PDF]
, 2008 No abstract ...
Hoggart, B. +3 more
core
Developmental Medicine &Child Neurology, EarlyView.This multicenter retrospective study evaluated the use of intravenous immunoglobulin (IVIG) in 14 children with Dravet syndrome as a preventive strategy against febrile status epilepticus. Over a 6‐month period, IVIG was associated with a significant reduction in hospitalizations for febrile status epilepticus.
Romane Marc +9 more
wiley +1 more source
Journal of the American Geriatrics Society, EarlyView.Cannabis use in older adults may have a broad range of effects in older adults impacting Mind, Mobility, Medications, Multi‐complexity, and what Matters Most.
Erik Fraunberger, Maia von Maltzahn
wiley +1 more source
Market Analysis of Plant-based Drugs C. The Cannabis Market [PDF]
, 2017 An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population ...
core
Cutaneous Wound Healing and the Effects of Cannabidiol [PDF]
Pearl Shah +10 more
openalex +1 more source
Journal of Paediatrics and Child Health, EarlyView.ABSTRACT Aim The aim of this Phase I/II open‐label study was to assess the safety and efficacy of NTI164, a novel full‐spectrum medicinal cannabis plant extract 0.08% Δ‐9‐tetrahydrocannabinol (THC), in Rett syndrome (RTT). Methods Eleven female participants (5–16 years) with a pathogenic variant in the MECP2 gene were recruited to this study, receiving
B. A. Keating +7 more
wiley +1 more source
Quick Reads, October 16, 2017 [PDF]
, 2017 IDPH Quick Reads is an electronic newsletter produced by the Director’s Office at the Iowa Department of Public Health.
core